Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Walters

Showing results (471-480 of 516) with videos related to

Pageof 52
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 21, 2012
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Naynesh R Kamani, Mark C Walters, Shelly Carter, et al.
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Nature Communications|May 26, 2021
Evolution of spin excitations from bulk to monolayer FeSeJonathan Pelliciari, Seher Karakuzu, Qi Song, et al.
American Journal of Hematology|February 12, 2024
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trialMary Eapen, Jianqun Kou, Martin Andreansky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directionsM C Walters, M Patience, W Leisenring, et al.
The New England Journal of Medicine|December 13, 2021
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell DiseaseJulie Kanter, Mark C Walters, Lakshmanan Krishnamurti, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
The Lancet. Haematology|September 10, 2019
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort studyMary Eapen, Ruta Brazauskas, Mark C Walters, et al.
The Review of Scientific Instruments|March 19, 2025
A millimeter-wave photometric camera for long-range imaging through optical obscurants using kinetic inductance detectorsJ Sayers, D Cunnane, S Crystian, et al.
Lancet (London, England)|November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trialJanet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Pageof 52

Showing results (471-480 of 516) with videos related to

Sort By:
Pageof 52
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 21, 2012
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Naynesh R Kamani, Mark C Walters, Shelly Carter, et al.
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Nature Communications|May 26, 2021
Evolution of spin excitations from bulk to monolayer FeSeJonathan Pelliciari, Seher Karakuzu, Qi Song, et al.
American Journal of Hematology|February 12, 2024
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trialMary Eapen, Jianqun Kou, Martin Andreansky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directionsM C Walters, M Patience, W Leisenring, et al.
The New England Journal of Medicine|December 13, 2021
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell DiseaseJulie Kanter, Mark C Walters, Lakshmanan Krishnamurti, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
The Lancet. Haematology|September 10, 2019
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort studyMary Eapen, Ruta Brazauskas, Mark C Walters, et al.
The Review of Scientific Instruments|March 19, 2025
A millimeter-wave photometric camera for long-range imaging through optical obscurants using kinetic inductance detectorsJ Sayers, D Cunnane, S Crystian, et al.
Lancet (London, England)|November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trialJanet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Pageof 52